An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease

被引:109
|
作者
Jarad, NA
Wedzicha, JA
Burge, PS
Calverley, PMA
机构
[1] London Chest Hosp, London E2 9JX, England
[2] Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England
[3] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
关键词
D O I
10.1016/S0954-6111(99)90001-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Withdrawal of inhaled corticosteroids is known to worsen disease control in bronchial asthma but similar data are lacking in chronic obstructive pulmonary disease (COPD). We hypothesized that clinical exacerbations requiring treatment would occur more often in patients whose inhaled corticosteroids were stopped than in other patients not treated with these agents. We studied 272 patients of mean age 65 (sD 0.8) years, mean FEV, 42.8 (sD 12.6)% predicted, entering the run-in phase of the Inhaled Steroids in Obstructive Lung Disease (ISOLDE) trial. All had been clinically stable for at least 6 weeks and there were no differences in the degree of bronchodilator reversibility, baseline lung function or pack-years of smoking between the 160 patients receiving inhaled corticosteroids and those not so treated. Inhaled corticosteroids were withdrawn in the first week of the study and during the remaining 7 weeks of the study 38% of those previously treated with these drugs had an exacerbation compared to 6% of the chronically untreated group. Patients receiving inhaled corticosteroids reported a longer duration of symptoms but neither this or any other recorded variable predicted the risk of exacerbation. These data suggest that abrupt withdrawal of inhaled corticosteroids should be monitored carefully even in patients with apparently irreversible COPD.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 50 条
  • [31] Prevalence of inhaled corticosteroid use among patients with chronic obstructive pulmonary disease: A survey
    Jackevicius, CA
    Chapman, KR
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (02) : 160 - 164
  • [32] The association between inhaled corticosteroid use and fractures in veterans with chronic obstructive pulmonary disease
    Lee, TA
    Bartle, B
    Xu, J
    Davis, KJ
    Weiss, KB
    CHEST, 2003, 124 (04) : 166S - 166S
  • [33] Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects
    Singh, Dave
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2020, 83 (03) : 185 - 194
  • [34] Inhaled Corticosteroids Withdrawal in Severe Patients With Chronic Obstructive Pulmonary Disease: A Wisdom Decision?
    Rodriguez Roisin, Robert
    Arismendi, Ebymar
    ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (02): : 57 - 58
  • [35] The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Reply
    Han, MeiLan K.
    Lipson, David A.
    Singh, Dave
    Martinez, Fernando J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (01) : 145 - 147
  • [36] The response to inhaled and oral steroids in patients with stable chronic obstructive pulmonary disease
    Weiner, P
    Weiner, M
    Rabner, M
    Waizman, J
    Magadle, R
    Zamir, D
    JOURNAL OF INTERNAL MEDICINE, 1999, 245 (01) : 83 - 89
  • [37] Triple inhaled therapy in stable chronic obstructive pulmonary disease: the earlier, the better?
    Antoniu, Sabina Antonela
    Carone, Mauro
    Sampablo, Italo
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (06) : 1039 - 1042
  • [38] Inhaled Corticosteroids Versus Placebo for Stable Chronic Obstructive Pulmonary Disease: A Review
    Kamalanathan, Erin
    Sharma, Sargam
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (07): : 455 - 458
  • [39] Risk of pneumonia with inhaled corticosteroids for stable chronic obstructive pulmonary disease patients
    Ruiz Garcia, Vicente
    Compte Torrero, Luis
    MEDICINA CLINICA, 2011, 137 (07): : 302 - 304
  • [40] Clusters in chronic obstructive pulmonary disease based on inhaled corticosteroid treatment and pneumonia incidence - a nationwide cohort study
    Klitgaard, Allan
    Ibsen, Rikke
    Hilberg, Ole
    Lokke, Anders
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62